StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · TLRY·Healthcare

Tilray Brands, Inc. Stock Analysis & AI Score

Tilray Brands, Inc. (TLRY) has an ST Score of 54.3 (B-), driven by its Forecast (A+) and held back by its Momentum (F). Analysts rate it Hold with a $65.01 price target (+1497.3% upside).

Market Closed
$4.07
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
54
ST Score
54.3/100B-

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

TLRY
54.3out of 100
Grade B-

Tilray Brands, Inc. (TLRY) has an ST Score of 54.3 (B-), driven by its Forecast (A+) and held back by its Momentum (F). Analysts rate it Hold with a $65.01 price target (+1497.3% upside).

Strongest
ForecastA+
Weakest
MomentumF
All factor grades
  • ForecastA+
  • ValuationA
  • GrowthB+
  • Financial StrengthB-
  • SentimentC+
  • ProfitabilityC
  • MomentumF
  • Piotroski3/9
Score methodology
Press Releases

Contact

TLRY stock: frequently asked questions

What is TLRY's ST Score?

Tilray Brands, Inc. (TLRY) has an ST Score of 54.3 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is TLRY a buy, hold, or sell?

Analysts rate TLRY a Hold, with a price target of $65.01 (+1497.3% vs the current price). Our ST Score grades it B- (54.3/100). The ST Score is a data-driven signal, not a recommendation.

What are TLRY's factor grades?

Valuation A, Profitability C, Financial Strength B-, Momentum F, Growth B+, Forecast A+, Sentiment C+.

What is TLRY's valuation grade?

Tilray Brands, Inc. (TLRY) earns a valuation grade of A, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is TLRY's growth grade?

Tilray Brands, Inc. (TLRY) earns a growth grade of B+, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is TLRY's profitability grade?

Tilray Brands, Inc. (TLRY) earns a profitability grade of C, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is TLRY's financial strength grade?

Tilray Brands, Inc. (TLRY) earns a financial strength grade of B-, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for TLRY?

The average analyst price target for Tilray Brands, Inc. (TLRY) is $65.01 from 20 analysts, which is +1497.3% versus the recent price of $4.07.

What is TLRY's Piotroski score?

Tilray Brands, Inc. (TLRY) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.